• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体视网膜牵拉的玻璃体切除术与观察的电子病历数据库研究

ELECTRONIC MEDICAL RECORD DATABASE STUDY OF VITRECTOMY AND OBSERVATION FOR VITREOMACULAR TRACTION.

作者信息

Jackson Timothy L, Donachie Paul H J, Johnston Robert L

机构信息

*Department of Ophthalmology, King's College London, London, United Kingdom; and †Department of Ophthalmology, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, United Kingdom.

出版信息

Retina. 2016 Oct;36(10):1897-905. doi: 10.1097/IAE.0000000000001012.

DOI:10.1097/IAE.0000000000001012
PMID:26966869
Abstract

PURPOSE

To audit the natural history of vitreomacular traction, and the risks and benefits of surgery.

METHODS

Database study of 1,254 patients (1,399 eyes) with vitreomacular traction from 16 UK vitreoretinal units.

RESULTS

The median age was 75 years, with 36.2% of patients diagnosed as diabetic. In 986 (70.5%) eyes managed conservatively, the median presenting logarithm of the minimum angle of resolution visual acuity of 0.30 (Snellen 20/40) was unchanged over follow-up. Of 413 eyes (29.5%) that required pars plana vitrectomy, the median preoperative visual acuity improved from 0.60 to 0.50 (20/80-20/63), 6 months to 12 months after surgery, with 33% gaining at least 0.3 units (approximately 2 Snellen lines). Vitrectomy was combined with internal limiting membrane peel in 43.8%, epiretinal membrane peel in 42.4%, gas/air tamponade in 46.2%, and cataract surgery in 27.9%. One or more intraoperative complications occurred in 12.6%; most commonly retinal breaks (8.0%), retinal trauma (1.9%), and retinal hemorrhage (1.0%). Postoperative retinal detachment occurred in 2.7% and macular hole in 2.2%. The 1, 2, and 3 year rates of postvitrectomy cataract surgery were 28.2%, 38.2%, and 42.7%, respectively.

CONCLUSION

Many eyes with vitreomacular traction have stable visual acuity. Those progressing to vitrectomy have relatively modest visual acuity gains, and complications are not infrequent.

摘要

目的

评估玻璃体黄斑牵拉的自然病程以及手术的风险和益处。

方法

对来自英国16个玻璃体视网膜单位的1254例(1399只眼)玻璃体黄斑牵拉患者进行数据库研究。

结果

患者中位年龄为75岁,36.2%的患者被诊断为糖尿病。在986只(70.5%)接受保守治疗的眼中,随访期间最小分辨角视力的初始对数中位数为0.30(Snellen 20/40),保持不变。在413只(29.5%)需要行玻璃体切割术的眼中,术后6个月至12个月,术前视力中位数从0.60提高到0.50(20/80 - 20/63),33%的患者视力至少提高0.3个单位(约2行Snellen视力表)。43.8%的患者在玻璃体切割术中联合内界膜剥除,42.4%联合视网膜前膜剥除,46.2%联合气体/空气填塞,27.9%联合白内障手术。12.6%的患者发生一种或多种术中并发症;最常见的是视网膜裂孔(8.0%)、视网膜损伤(1.9%)和视网膜出血(1.0%)。术后视网膜脱离发生率为2.7%,黄斑裂孔发生率为2.2%。玻璃体切割术后白内障手术的1年、2年和3年发生率分别为28.2%、38.2%和42.7%。

结论

许多玻璃体黄斑牵拉患者的视力稳定。那些需要进行玻璃体切割术的患者视力提高相对有限,且并发症并不少见。

相似文献

1
ELECTRONIC MEDICAL RECORD DATABASE STUDY OF VITRECTOMY AND OBSERVATION FOR VITREOMACULAR TRACTION.玻璃体视网膜牵拉的玻璃体切除术与观察的电子病历数据库研究
Retina. 2016 Oct;36(10):1897-905. doi: 10.1097/IAE.0000000000001012.
2
THE ROYAL COLLEGE OF OPHTHALMOLOGISTS' NATIONAL OPHTHALMOLOGY DATABASE STUDY OF VITREORETINAL SURGERY: Report 4, Epiretinal Membrane.皇家眼科医学院玻璃体视网膜手术全国眼科数据库研究:报告4,视网膜前膜
Retina. 2015 Aug;35(8):1615-21. doi: 10.1097/IAE.0000000000000523.
3
Pars plana vitrectomy for vitreomacular traction syndrome: a systematic review and metaanalysis of safety and efficacy.经平坦部玻璃体切除术治疗玻璃黄斑牵拉综合征:安全性和疗效的系统评价和荟萃分析。
Retina. 2013 Nov-Dec;33(10):2012-7. doi: 10.1097/IAE.0b013e3182a6b3e2.
4
United Kingdom National Ophthalmology Database study of vitreoretinal surgery: report 2, macular hole.英国国家眼科数据库玻璃体视网膜手术研究:报告 2,黄斑裂孔。
Ophthalmology. 2013 Mar;120(3):629-634. doi: 10.1016/j.ophtha.2012.09.003. Epub 2012 Dec 1.
5
[Diseases of the vitreo-macular interface].[玻璃体黄斑界面疾病]
Klin Monbl Augenheilkd. 1999 May;214(5):305-10. doi: 10.1055/s-2008-1034801.
6
ANATOMICAL AND FUNCTIONAL OUTCOMES OF SYMPTOMATIC IDIOPATHIC VITREOMACULAR TRACTION: A Natural History Study From the Pan American Collaborative Retina Study Group.症状性特发性玻璃体黄斑牵拉的解剖学和功能转归:泛美视网膜协作研究组的一项自然史研究
Retina. 2016 Oct;36(10):1913-8. doi: 10.1097/IAE.0000000000001015.
7
LONG-TERM OUTCOMES OF 23-GAUGE PARS PLANA VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING AND GAS TAMPONADE FOR MYOPIC TRACTION MACULOPATHY: A Prospective Study.23G经睫状体平坦部玻璃体切除术联合内界膜剥除及气体填充治疗近视性牵引性黄斑病变的长期疗效:一项前瞻性研究
Retina. 2015 Sep;35(9):1836-43. doi: 10.1097/IAE.0000000000000554.
8
Clinical Course of Vitreomacular Traction Managed Initially by Observation.初以观察处理的玻璃体黄斑牵拉的临床病程
Ophthalmic Surg Lasers Imaging Retina. 2015 May;46(5):571-6. doi: 10.3928/23258160-20150521-09.
9
A retrospective cohort study in patients with tractional diseases of the vitreomacular interface (ReCoVit).一项针对玻璃体黄斑界面牵引性疾病患者的回顾性队列研究(ReCoVit)。
Graefes Arch Clin Exp Ophthalmol. 2016 Apr;254(4):617-28. doi: 10.1007/s00417-016-3294-1. Epub 2016 Feb 22.
10
[Vitrectomy for vitreo-macular traction syndrome].[玻璃体黄斑牵引综合征的玻璃体切除术]
Klin Monbl Augenheilkd. 2003 Mar;220(3):122-6. doi: 10.1055/s-2003-38191.

引用本文的文献

1
A Causal Inference Approach to Mediation Analysis in Vitreomacular Traction: How Much Does Traction Resolution Mediate Functional Outcomes?玻璃体黄斑牵引中中介分析的因果推断方法:牵引解除对功能结局的中介作用有多大?
J Mark Access Health Policy. 2024 Sep 30;12(4):280-293. doi: 10.3390/jmahp12040022. eCollection 2024 Dec.
2
[Vitreomacular traction: diagnostics, natural course, treatment decision and guideline recommendations].[玻璃体黄斑牵拉:诊断、自然病程、治疗决策及指南推荐]
Ophthalmologie. 2024 Jun;121(6):470-475. doi: 10.1007/s00347-024-02042-4. Epub 2024 May 29.
3
Pars plana vitrectomy for tractional diabetic macular edema with or without internal limiting membrane peeling.
用于治疗有或无内界膜剥除的牵引性糖尿病性黄斑水肿的玻璃体切除术。
Med Hypothesis Discov Innov Ophthalmol. 2022 Dec 3;11(3):110-118. doi: 10.51329/mehdiophthal1454. eCollection 2022 Fall.
4
Visual functional changes after ocriplasmin injection for vitreomacular traction: A microperimetric analysis.玻璃体内注射奥克纤溶酶治疗玻璃体黄斑牵引后的视觉功能变化:微视野分析
Taiwan J Ophthalmol. 2020 Dec 4;11(3):259-265. doi: 10.4103/tjo.tjo_57_20. eCollection 2021 Jul-Sep.
5
Patient-reported outcomes of ocriplasmin for the treatment of vitreomacular traction: a systematic review and synthesis of the literature.患者报告的奥克纤溶酶治疗玻璃体黄斑牵引的疗效:文献的系统评价与综合分析
Patient Relat Outcome Meas. 2019 Mar 27;10:101-116. doi: 10.2147/PROM.S153718. eCollection 2019.
6
Effect of intravitreal CF gas in patients with vitreomacular traction: A retrospective case series.玻璃体腔注射CF气体治疗玻璃体黄斑牵拉患者的疗效:一项回顾性病例系列研究。
Spektrum Augenheilkd. 2018;32(6):228-238. doi: 10.1007/s00717-017-0382-5. Epub 2017 Dec 11.
7
Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole.玻璃体内注射奥克纤溶酶治疗玻璃体黄斑牵引和黄斑裂孔的成本效益
J Mark Access Health Policy. 2016 Jun 23;4. doi: 10.3402/jmahp.v4.31472. eCollection 2016.